Evaluating the Association Between Genetic Polymorphisms Related to Homocysteine Metabolism and Unexplained Recurrent Pregnancy Loss in Women
Nhat Nguyen Ngoc,My Tran Ngoc Thao,Sang Trieu Tien,Son Vu Tung,Hoang Le,Hung Ho Sy,Tung Nguyen Thanh,Son Trinh The
DOI: https://doi.org/10.2147/TACG.S365281
2022-06-08
The Application of Clinical Genetics
Abstract:Nhat Nguyen Ngoc, 1 My Tran Ngoc Thao, 2 Sang Trieu Tien, 3 Son Vu Tung, 4 Hoang Le, 5 Hung Ho Sy, 6 Tung Nguyen Thanh, 1 Son Trinh The 1 1 Military Institute of Clinical Embryology and Histology, Vietnam Military Medical University, Hanoi, 12108, Vietnam; 2 Département de formation Biologie moléculaire et cellulaire, Sorbonne University, Paris, 75006, France; 3 Department of Biology and Genetics, Vietnam Military Medical University, Hanoi, 12108, Vietnam; 4 Department of Epidemiology, Vietnam Military Medical University, Hanoi, 12108, Vietnam; 5 IVFTA, Tam Anh General Hospital, Hanoi, 100000, Vietnam; 6 Department of Obstetrics and Gynecology, Hanoi Medical University, Hanoi, 100000, Vietnam Correspondence: Son Trinh The; Tung Nguyen Thanh, Military Institute of Clinical Embryology and Histology, Vietnam Military Medical University, Hanoi, 12108, Vietnam, Email ; Objective: To investigate the relationship between unexplained recurrent pregnancy loss (URPL) and polymorphisms of homocysteine metabolism-related genes in women. Materials and Methods: A case–control study included 90 women with two or more consecutive unexplained pregnancy losses and 92 controlled women without miscarriage history; the female participants were in the age category of 18– 35 years. The high-resolution melting technique was used to detect the single-nucleotide variants related to homocysteine metabolism disorder, namely MTHFR C677T, MTHFR A1298C, MTR A2756G, and MTRR A66G polymorphism. Results: The MTHFR C677T polymorphism had significantly correlation with URPL. Indeed, the frequency of the677T allele and genotypes (677CT, 677TT) in the URPL group was significantly higher than that in the control group (p < 0.05). However, the allele, as well as genotype distribution of MTHFR A1298C, MTR A2756G, and MTRR A66G polymorphisms showed no significant difference (p > 0.05). MTHFR 677CT-1298AC genotype combination led to a 9.0-fold increased risk of URPL (OR 9.0; 95% CI, 2.25– 35.99; p = 0.001), while the risk increased 10.0-fold (OR 10.0; 95% CI, 1.8– 55.53; p = 0.008) when participants had more than the 3 variant loci. Conclusion: The MTHFR C677T polymorphism was a risk factor for URPL, and determining the MTHFR C677T polymorphism had a potential prediction of URPL risk. Moreover, the MTHFR C677T and MTHFR A1298C joint mutants might have a synergistic effect on URPL. Conversely, there is a lack of evidence suggesting the URPL risk of MTHFR A1298C, MTR A2756G, and MTRR A66G polymorphisms. Keywords: unexplained recurrent pregnancy loss, homocysteine, MTHFR C677T, MTHFR A1298C, MTR A2756G, MTRR A66G According to the Practice Committee of the American Society for Reproductive Medicine, the term "recurrent pregnancy loss" (RPL) is defined as experiencing two or more spontaneous miscarriages occurring within 20 weeks of gestation. 1,2 By studying the incidence of RPL through various researches worldwide, this condition was reported to affect up to 1–5% of women of reproductive age seeking pregnancy, which leaves a significant adverse impact on couples and society. Recurrent pregnancy loss is multifactorial; the recognized diverse causes of RPL include parental chromosomal abnormalities, immunological factors, uterine anomalies, endocrine disturbances, and even lifestyle. However, the causes are unidentifiable in 50% of the patients who are classified as experiencing unexplained recurrent pregnancy loss (URPL). 3–5 Recently, it has been discovered that there exists an association between URPL and genetic polymorphisms related to inherited thrombophilic factors such as Factor V Leiden (FV), plasminogen activator inhibitor-1 (PAI-1), homocysteine metabolism, and so on. 6,7 Homocysteine (Hcy) is an amino acid made from methionine by losing its terminal methyl group, and the remethylation generating methionine requires folate and vitamin B12. Three main enzymes are involved in the metabolic pathway: methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR). Polymorphisms in the genes encoding for these enzymes have been suggested to be responsible for the altered enzyme activity that eventually accumulates homocysteine which may directly damage the endothelium and influence placental function as well as perfusion. 8,9 Hence, hyperhomocysteine during pregnancy was associated with recurrent pregnancy loss, preeclampsia, and placental abruption. -Abstract Truncated-
English Else